BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18503264)

  • 1. SAMFA: simplifying molecular description for 3D-QSAR.
    Manchester J; Czermiński R
    J Chem Inf Model; 2008 Jun; 48(6):1167-73. PubMed ID: 18503264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CAUTION: popular "benchmark" data sets do not distinguish the merits of 3D QSAR methods.
    Manchester J; Czermiński R
    J Chem Inf Model; 2009 Jun; 49(6):1449-54. PubMed ID: 19438212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical confidence for variable selection in QSAR models via Monte Carlo cross-validation.
    Konovalov DA; Sim N; Deconinck E; Vander Heyden Y; Coomans D
    J Chem Inf Model; 2008 Feb; 48(2):370-83. PubMed ID: 18232680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational study of histamine H3-receptor antagonist with support vector machines and three dimension quantitative structure activity relationship methods.
    Chen HF
    Anal Chim Acta; 2008 Aug; 624(2):203-9. PubMed ID: 18706326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TMACC: interpretable correlation descriptors for quantitative structure-activity relationships.
    Melville JL; Hirst JD
    J Chem Inf Model; 2007; 47(2):626-34. PubMed ID: 17381177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of ordinal CoMFA by ridge logistic partial least squares.
    Ohgaru T; Shimizu R; Okamoto K; Kawashita N; Kawase M; Shirakuni Y; Nishikiori R; Takagi T
    J Chem Inf Model; 2008 Apr; 48(4):910-7. PubMed ID: 18338844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecule kernels: a descriptor- and alignment-free quantitative structure-activity relationship approach.
    Mohr JA; Jain BJ; Obermayer K
    J Chem Inf Model; 2008 Sep; 48(9):1868-81. PubMed ID: 18767832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling and prediction of retention behavior of histidine-containing peptides in immobilized metal-affinity chromatography.
    Tian F; Yang L; Lv F; Zhou P
    J Sep Sci; 2009 Jun; 32(12):2159-69. PubMed ID: 19548218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinatorial QSAR modeling of specificity and subtype selectivity of ligands binding to serotonin receptors 5HT1E and 5HT1F.
    Wang XS; Tang H; Golbraikh A; Tropsha A
    J Chem Inf Model; 2008 May; 48(5):997-1013. PubMed ID: 18470978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QSAR of aminopyrido[2,3-d]pyrimidin-7-yl derivatives: anticancer drug design by computed descriptors.
    Nandi S; Bagchi MC
    J Enzyme Inhib Med Chem; 2009 Aug; 24(4):937-48. PubMed ID: 19555178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
    Mandal AS; Roy K
    Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR models for the human H(+)/peptide symporter, hPEPT1: affinity prediction using alignment-independent descriptors.
    Larsen SB; Jørgensen FS; Olsen L
    J Chem Inf Model; 2008 Jan; 48(1):233-41. PubMed ID: 18092768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robust cross-validation of linear regression QSAR models.
    Konovalov DA; Llewellyn LE; Vander Heyden Y; Coomans D
    J Chem Inf Model; 2008 Oct; 48(10):2081-94. PubMed ID: 18826208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LQTA-QSAR: a new 4D-QSAR methodology.
    Martins JP; Barbosa EG; Pasqualoto KF; Ferreira MM
    J Chem Inf Model; 2009 Jun; 49(6):1428-36. PubMed ID: 19422246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacophore-based 3D-QSAR of HIF-1 inhibitors.
    Chung JY; Pasha FA; Cho SJ; Won M; Lee JJ; Lee K
    Arch Pharm Res; 2009 Mar; 32(3):317-23. PubMed ID: 19387572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of multivariate image analysis applied to quantitative structure-activity relationship (QSAR) analysis by using wavelet-principal component analysis ranking variable selection and least-squares support vector machine regression: QSAR study of checkpoint kinase WEE1 inhibitors.
    Cormanich RA; Goodarzi M; Freitas MP
    Chem Biol Drug Des; 2009 Feb; 73(2):244-52. PubMed ID: 19207427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the physical interpretation of QSAR models.
    Stanton DT
    J Chem Inf Comput Sci; 2003; 43(5):1423-33. PubMed ID: 14502475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimized block-wise variable combination by particle swarm optimization for partial least squares modeling in quantitative structure-activity relationship studies.
    Lin WQ; Jiang JH; Shen Q; Shen GL; Yu RQ
    J Chem Inf Model; 2005; 45(2):486-93. PubMed ID: 15807514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total and local (atom and atom type) molecular quadratic indices: significance interpretation, comparison to other molecular descriptors, and QSPR/QSAR applications.
    Ponce YM
    Bioorg Med Chem; 2004 Dec; 12(24):6351-69. PubMed ID: 15556754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QSAR studies of CYP2D6 inhibitor aryloxypropanolamines using 2D and 3D descriptors.
    Roy PP; Roy K
    Chem Biol Drug Des; 2009 Apr; 73(4):442-55. PubMed ID: 19291105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.